Log in to search using one of your social media accounts:

 

Fire ant venom could treat psoriasis, scientists claim

In trials on mice at the Emory University School of Medicine, Atlanta, the new cream was showed to reduce skin thickening and inflammation - both are typical features of the incurable disorder.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

Condition:   Psoriasis Vulgaris Interventions:   Drug: ethosomal preparation of anthralin;   Drug: liposomal preparation of anthralin Sponsor:   Assiut University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Disease duration joins severity as a factor driving CV risk in patients with psoriasis, but the right therapy can lower this risk.Medscape Dermatology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Dermatology Viewpoint Source Type: news
Condition:   Psoriasis Vulgaris Interventions:   Drug: ethosomal preparation of anthralin;   Drug: liposomal preparation of anthralin Sponsor:   Assiut University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
People with the skin disease psoriasis are at increased risk for type 2 diabetes, and the more severe the psoriasis, the greater their risk, a new study finds.
Source: WebMD Health - Category: Consumer Health News Source Type: news
Title: Severe Psoriasis May Make Diabetes Increasingly LikelyCategory: Health NewsCreated: 11/20/2017 12:00:00 AMLast Editorial Review: 11/21/2017 12:00:00 AM
Source: MedicineNet Diabetes General - Category: Endocrinology Source Type: news
Psoriasis is a chronic inflammatory skin disease characterized by the infiltration of T cell and other immune cells to the skin in response to injury or autoantigens. Conventional, as well as unconventional, γδ T cells are recruited to the dermis and epidermis by CCL20 and other chemokines. Together with its...
Source: Proceedings of the National Academy of Sciences - Category: Science Authors: Tags: Biological Sciences Source Type: research
Psoriasis is an immune-mediated, inflammatory and hyperproliferative disease of the skin and joints. The cause of psoriasis is still unknown. The fundamental feature of the disease is the hyperproliferation of keratinocytes and the recruitment of cells from the immune system in the region of the affected skin, which leads to deregulation of many well-known gene expressions.
Source: Journal of Dermatological Science - Category: Dermatology Authors: Source Type: research
Source: HealthDay Related MedlinePlus Pages: Diabetes, Psoriasis
Source: MedlinePlus Health News - Category: Consumer Health News Source Type: news
Endogenous Glucocorticoid Deficiency in Psoriasis Promotes Inflammation and Abnormal Differentiation
Source: Journal of Investigative Dermatology - Category: Dermatology Tags: Erratum Source Type: research
The authors of this study explain that secukinumab has demonstrated significant efficacy with a good safety profile through 1 year in the treatment of plaque psoriasis. They set out to determine the long-term (3-year) efficacy and safety of secukinumab in moderate-to-severe psoriasis. In total, 168 patients receiving secukinumab 300 mg on a fixed-interval schedule, and 172 receiving secukinumab 300 mg retreatment as needed entered this extension study. Secukinumab 300 mg fixed interval sustained high efficacy: at the end of year 3, the proportion of responders achieving ≥ 90% improvement in Psoriasis Area and Severity I...
Source: Journal of Investigative Dermatology - Category: Dermatology Tags: Editorial Source Type: research
More News: Health | Psoriasis | Skin